What are the indications for ensidipine?

Enasidenib is a targeted therapy drug, mainly suitable for patients with relapsed or refractory acute myeloid leukemia (AML) who carry IDH2 mutations. AMLIt is a malignant tumor caused by the abnormal proliferation and maturation block of abnormal leukemia stem cells in the bone marrow. It usually leads to clinical symptoms such as anemia, bleeding, and infection, which seriously affects the patient's quality of life and prognosis.

Ensidipine, as a targeted therapy drug, targets the subgroup of AML patients carrying IDH2 mutations and has a unique mechanism of action. It achieves therapeutic effects by inhibiting abnormal enzyme activity caused by IDH2 mutations, interfering with abnormal metabolic pathways and inducing AML cell apoptosis. Therefore, the main indications for ensidipine include the following:

1.Relapsed or refractory acute myeloid leukemia (AML): Ensidipine is mainly suitable for patients with relapsed or refractory AML who carry IDH2 mutations. These patients often experience failure or relapse with conventional treatments and have limited response to other treatments.

2.Patients with AML carrying IDH2 mutations: Ensidipine is an important treatment option for a specific subpopulation of AML patients, namely those carrying IDH2 mutations. IDH2Mutation is a common molecular abnormality in AML. For these patients, ensidipine can significantly improve the condition and improve survival rate.

3.Further studies in clinical trials: In addition to its approved indications, ensidipine may be studied more extensively in clinical trials to explore its potential use in other types of leukemias and malignancies. These clinical trials may expand the scope of indications for ensidipine and provide treatment hope for more patients.

In general, ensidipine is an important drug for targeted treatment of AML and is suitable for patients with relapsed or refractory AML carrying IDH2 mutations. Although its indications are relatively narrow, for patients who meet the indications, ensidipine can provide an effective treatment option, improve the condition and improve survival rates.